封装在β-环氧德克斯特林纳米海绵中的黑色素的宿主-客的动态行为
Riccardo Ferrero1, Stefano Pantaleone1, Valentina Brunella1
1Dipartimento di Chimica and NIS Interdepartmental Centre, Università degli Studi di Torino, Via P. Giuria 7, 10125 Torino, Italy.
ACS omega
|February 17, 2025
概括
使用分子动力学建模的循环德克斯特林纳米海绵显示了增强的药物相互作用. 黑色素封装受益于这些多孔纳米材料中的多价值和拥挤效应.
科学领域:
- 纳米材料科学 科学 纳米材料科学
- 计算化学计算化学
- 药物输送系统 药物输送系统
背景情况:
- 基于环德的纳米海绵是具有高表面积的多孔纳米材料,适合用于药物封装.
- 它们的复杂结构需要先进的计算方法来进行详细的分析.
- 作为一种神经激素的黑激素具有作为抗氧化剂和免疫调节剂的潜在治疗应用.
研究的目的:
- 开发用于与酸交叉连接的β-cyclodextrin纳米海绵的全原子模型.
- 通过分子动力学模拟来研究这些纳米海绵的灵活性.
- 分析纳米海绵和封装的黑素之间的相互作用.
主要方法:
- 构建线性和周期性β-cyclodextrin-酸纳米海绵的全原子模型.
- 广泛的分子动力学 (MD) 模拟来评估纳米海绵的灵活性.
- 药物-纳米海绵相互作用的特征,重点关注黑素结合.
主要成果:
- 为具有线性和循环拓的β-环氧素纳米海绵生成了详细的原子模型.
- 分子动力学模拟揭示了这些纳米结构结构的灵活性.
- 确定了控制黑激素结合的关键相互作用,突出显示了多价值和拥挤的好处.
结论:
- 计算机建模为循环德克斯特林纳米海绵及其药物相互作用提供了有价值的原子学见解.
- 这些纳米海绵中的黑素封装受到多价值和拥挤效应的有利影响.
- 这项研究促进了对纳米海绵用于增强药物输送应用的理解.
相关概念视频
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143


